4//SEC Filing
Kintz Samuel 4
Accession 0001967168-25-000005
CIK 0001672619other
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 7:42 PM ET
Size
5.1 KB
Accession
0001967168-25-000005
Insider Transaction Report
Form 4
Kintz Samuel
DirectorPRESIDENT AND CEO
Transactions
- Sale
Common Stock
2025-09-23$20.03/sh−2,800$56,084→ 919,092 total(indirect: See footnote)
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024.
- [F2]The shares are held of record by The Kintz & Egan Trust Dated March 30, 2019 for which the reporting person serves as trustee.
Documents
Issuer
Enliven Therapeutics, Inc.
CIK 0001672619
Entity typeother
Related Parties
1- filerCIK 0001967168
Filing Metadata
- Form type
- 4
- Filed
- Sep 24, 8:00 PM ET
- Accepted
- Sep 25, 7:42 PM ET
- Size
- 5.1 KB